Podcast
Hear the podcastG. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech posts gain in February as broader markets strengthen March 03, 2010 | Press Release
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
See all News
Bryant E. Fong
Managing DirectorPrior to joining Burrill & Company in 1998, Mr. Fong held positions as a biochemist and molecular biologist with two early-stage biotechnology companies located in the San Francisco Bay Area. His research experiences include recombinant protein expression in yeast, development of linear artificial chromosomes, and catalytic RNA technology.
Mr. Fong earned his bachelors degree with distinction and honors in Molecular and Cell Biology-Biochemistry from the University of California, Berkeley.
Mr. Fong currently serves on the Boards of Directors of FerroKin Biosciences, Nora Therapeutics, Neurotech Pharmaceuticals, Odyssey Thera, TRF Pharma, and Logical Therapeutics (observer).



